Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Input Field |
Entered |
---|---|
SERIAL NUMBER | 88248334 |
LAW OFFICE ASSIGNED | LAW OFFICE 104 |
MARK SECTION | |
MARK FILE NAME | http://uspto.report/TM/88248334/mark.png |
LITERAL ELEMENT | ANDRODERM |
STANDARD CHARACTERS | NO |
USPTO-GENERATED IMAGE | NO |
COLOR(S) CLAIMED (If applicable) |
Color is not claimed as a feature of the mark. |
DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the word ANDRODERM in stylized letters in which the letter "O" consists of the male symbol. |
ARGUMENT(S) | |
Pursuant to the Trademark Assignment Agreement with an effective date of December 31, 2015, between Actavis Laboratories UT, Inc., and Allergan Sales, LLC, Allergan Sales LLC is the owner of U. S. Registration Nos. 1933484 and 1963460 for the ANDRODERM word mark. The Assignment was filed with the Assignment Branch on August 26, 2019 and received receipt ID: TM538105 As the Applicant is also the owner of the cited prior ANDRODERM word mark registrations, the goods offered under all three ANDRODERM trademarks originate from a common source. Accordingly, consumers will not be confused as to the origination of the goods. Applicant therefore respectfully requests that its Serial No. 88248334, for the ANDRODERM with a design element, be approved and proceed to publication. | |
EVIDENCE SECTION | |
EVIDENCE FILE NAME(S) | |
ORIGINAL PDF FILE | evi_1621163325-20190826140427818963_._ark_Assignment_Agmt_-_Actavis_Labs_UT_to_Allergan_Sales__LLC.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\882\483\88248334\xml6\ROA0002.JPG |
\\TICRS\EXPORT17\IMAGEOUT17\882\483\88248334\xml6\ROA0003.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\882\483\88248334\xml6\ROA0004.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\882\483\88248334\xml6\ROA0005.JPG | |
DESCRIPTION OF EVIDENCE FILE | a Trademark Assignment Agreement dated as of December 31, 2015 between Actavis Laboratories UT, Inc., and Allergan Sales, LLC, whereby Actavis Laboratories UT assigned U. S. Registration Nos. 1933484 and 1963460 to Allergan Sales, LLC. |
ADDITIONAL STATEMENTS SECTION | |
DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the wording "ANDRODERM" in stylized letters in which the letter "O" consists of the male biological symbol. |
SIGNATURE SECTION | |
RESPONSE SIGNATURE | /mob/ |
SIGNATORY'S NAME | Matthew O. Brady |
SIGNATORY'S POSITION | Vice President |
SIGNATORY'S PHONE NUMBER | 714-246-5507 |
DATE SIGNED | 08/26/2019 |
AUTHORIZED SIGNATORY | YES |
FILING INFORMATION SECTION | |
SUBMIT DATE | Mon Aug 26 15:18:09 EDT 2019 |
TEAS STAMP | USPTO/ROA-XXX.XXX.XX.XX-2 0190826151809944428-88248 334-610fb54e9fcb8588b1f9d 521d41e8daf8f76b25725758e d4f87f5ec75d5533a49-N/A-N /A-20190826140427818963 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |